SURMODICS INC — Director's Dealing 2023

Dec 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2023-11-30

Reporting Person: SIDES TERI WOODWICK (SVP, Vascular Interventions)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-30	Common Stock	F	436	$32.82	Disposed	28343	Direct
2023-11-30	Common Stock	F	465	$32.82	Disposed	27878	Direct
2023-11-30	Common Stock	F	848	$32.82	Disposed	27030	Direct

Footnotes

F1: Includes 670 shares acquired through the Employee Stock Purchase Plan for the phase ending on 2/28/23 and 92 for the phase ending on 8/31/23.